N Trotsko - European Journal of Medicinal Chemistry, 2021 - Elsevier
Thiazolidin-4-one scaffold has great potential for medicinal chemistry and is of interest to scientists in view of wide spectrum of biological activity. This scaffold is often used for …
AKD bin Ahmad Kamar, LJ Yin, CT Liang… - Medicine in Drug …, 2022 - Elsevier
Diabetes is a chronic medical condition due to the lack of insulin or ineffective use of insulin. In recent years, diabetes has become one of the rapidly growing chronic diseases, and it …
A Chaurasyia, P Chawla, V Monga… - Chemical Biology & …, 2023 - Wiley Online Library
Abstract Rhodanine or 2‐Thioxothiazolidin‐4‐one is a privileged heterocyclic compound offering a wide opportunity for structural modification, lead development, and modification. It …
S Cheng, Y Zou, X Chen, J Chen, B Wang… - European Journal of …, 2023 - Elsevier
Mycobacterium tuberculosis infections still pose a serious threat to human health. Combination therapies are effective medical solutions to the problem. Mycobacterium …
V Šlachtová, M Šebela, E Torfs, L Oorts… - European Journal of …, 2020 - Elsevier
Abstract Zinc metalloprotease 1 (Zmp1) is an extracellular enzyme, which has been found essential for the intracellular survival and pathogenesis of Mycobacterium tuberculosis. In …
Asymmetric total synthesis of cyclotetradepsipeptide beauveamide A has been achieved for the first time. A macrolactamization strategy involving two possible sites has been explored …
M Dak, V Šlachtová, M Šebela, V Bazgier… - European Journal of …, 2022 - Elsevier
Abstract Mycobacterial zinc metalloprotease-1 (Zmp1) is an essential enzyme for intracellular survival and pathogenicity of Mycobacterium tuberculosis. However, the exact …
Rhodanines are five-member heterocyclics having sulfur, nitrogen, and oxygen atoms in their ring structure and exhibit potent as well as a broad range of pharmacological activities …
NAD Khalaf, HA Hasan, KF Ali - F1000Research, 2023 - f1000research.com
Background: Epidermal growth factor receptor (EGFR) is seen in almost all cases of non- small cell lung cancer (NSCLC). As a result, targeting EGFR has become an attractive …